SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-22-000047
Filing Date
2022-03-03
Accepted
2022-03-03 18:26:56
Documents
1
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164635000300476.html 3  
1 FORM 3 wf-form3_164635000300476.xml 3 5794
  Complete submission text file 0001367644-22-000047.txt   7146
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address
Fox Jennifer Lynne (Reporting) CIK: 0001914879 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 22710980